Kenneth T. Jones

Insider Reports History

Entity
Individual
Location
C/O Zynerba Pharmaceuitcals, Inc., 80 W. Lancaster Avenue, Suite 300, Devon, PA
Signature
/s/ Albert P. Parker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth T. Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zynerba Pharmaceuticals, Inc. Vice President, Corporate Controller and Interim Chief Financial Officer Common Stock 0 $1.33 Oct 10, 2023 Direct
Zynerba Pharmaceuticals, Inc. Vice President, Corporate Controller and Interim Chief Financial Officer Stock Option (Right to Buy) 0 Oct 10, 2023 Direct

Insider Reports Filed by Kenneth T. Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYNE Zynerba Pharmaceuticals, Inc. Oct 10, 2023 4 $0 4 Oct 11, 2023 Vice President, Corporate Controller and Interim Chief Financial Officer
ZYNE Zynerba Pharmaceuticals, Inc. Sep 12, 2023 2 -$3.32K 4 Sep 14, 2023 Vice President, Corporate Controller and Interim Chief Financial Officer
ZYNE Zynerba Pharmaceuticals, Inc. Aug 8, 2023 0 $0 3 Aug 15, 2023 Officer